Company Quick10K Filing
Dougherty's Pharmacy
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 23 $2
10-Q 2019-05-20 Quarter: 2019-03-31
10-K 2019-05-06 Annual: 2018-12-31
10-Q 2019-04-29 Quarter: 2018-09-30
10-Q 2018-08-14 Quarter: 2018-06-30
10-Q 2018-05-11 Quarter: 2018-03-31
10-K 2018-03-29 Annual: 2017-12-31
10-Q 2017-11-13 Quarter: 2017-09-30
10-Q 2017-08-14 Quarter: 2017-06-30
8-K 2019-08-28 Enter Agreement, M&A, Bankruptcy, Other Events, Exhibits
8-K 2019-06-10 Enter Agreement, M&A, Shareholder Vote, Other Events
8-K 2019-02-07 Officers, Exhibits
8-K 2018-08-14 Earnings, Regulation FD, Exhibits
8-K 2018-08-01 Off-BS Arrangement
8-K 2018-06-12 Shareholder Vote
8-K 2018-05-22 Other Events, Exhibits
8-K 2018-05-14 Earnings, Regulation FD, Exhibits
8-K 2018-03-29 Earnings, Regulation FD, Exhibits
8-K 2018-02-28 Other Events, Exhibits
8-K 2018-02-20 Other Events, Exhibits
8-K 2018-01-17 Officers, Exhibits

Dougherty's Pharmacy Financials

MYDP Metrics, Comps, Filings

Annual | Quarterly

Business

Dougherty's Pharmacy, Inc. (“Dougherty's,” which is also referred to in this Annual Report as “we,” “us,” or “the Company”) is a value oriented company focused on successfully acquiring, managing and growing community based pharmacies in the Southwest Region. Dougherty's was incorporated as Ascendant Solutions, Inc. in Delaware on August 8, 2000. On May 10th, 2017, the Company amended its Certificate of Incorporation to change its name from “Ascendant Solutions, Inc.” to “Dougherty's Pharmacy, Inc.” to reflect the current focus and operating structure from the previous focus on making equity investments in underperforming or distressed U.S. lower middle-market businesses in the manufacturing, distribution, service, healthcare, finance and retail industries. Since December 31, 2013, the Company investments included its wholly owned subsidiary Dougherty's Holdings, Inc. (“DHI”), under which it operates its retail pharmacy business and its wholly owned subsidiary ASDS of Orange County, Inc. which operated as a holding company for the investment in CRESA Partners of Orange County, Inc., a tenant representation and real estate advisory services company that was liquidated on February 7, 2017.

Effective December 31, 2013, the Company changed its focus to acquire, manage, and grow community-based pharmacies in the Southwest Region of the United States, and since then has engaged in a number of acquisition transactions to expand our pharmacy business and to minimize and ultimately divest our other business interests.

On August 4, 2014, DHI acquired the patient prescription files of Family Pharmacy located in Lewisville, Texas.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Quantrx Biomedical (QTXB) 2,361 -4.4 -159% 440 2,156 0 0 -699 -496 2,160
Evolutionary Genomics (FNAM) 2,353 0% -3.3 -14% 4,589 976 198 0 -647 -607 2,008
Mount Tam Biotechnologies (MNTM) 2,228 -1.9 -2,095% 59 2,661 0 0 -1,230 -1,149 2,187
Electronic Systems Technology (ELST) 2,227 52% -14.5 -7% 2,027 150 1,395 722 -142 -138 2,002
iSIGN Solutions (ISGN) 2,190 0% -2.0 -259% 366 5,404 904 0 -949 -946 1,912
Prestige Capital (PGEC) 2,166 -92.8 -18,504% 0 193 0 0 -28 -23 2,166
Egalet (EGLT) 2,150 0% -1.1 -43% 235,573 177,894 54,493 0 -101,264 -87,285 99,856
Enviro Technologies (EVTN) 2,147 44% -5.5 -15% 2,201 3,057 1,335 593 -339 -319 1,752
Mountain High Acquisitions (MYHI) 2,085 56% -0.4 -1,026% 471 355 141 79 -4,834 -4,746 2,007
Dougherty's Pharmacy (MYDP) 2,079 33% -95.8 -40% 8,462 10,364 27,384 9,125 -3,358 -41 3,927
Nulife Sciences (NULF) 2,078 51% -0.6 -4,308% 87 1,851 7 4 -3,735 -3,609 2,205
Aly Energy Services (ALYE) 2,030 0% 1.6 2% 34,963 9,545 16,828 0 553 3,896 6,391
Procyon (PCYN) 1,997 73% 16.5 1% 2,435 376 4,191 3,050 27 103 1,706
Sangui Biotech International (SGBI) 1,993 100% -7.8 -478% 51 529 75 75 -243 -254 1,974
Proteo (PTEO) 1,990 0% -8.0 -85% 276 897 15 0 -235 -235 1,868
Capital Financial Holdings (CPFH) 1,986 0% -0.8 -8% 4,781 3,214 14,754 0 -375 -303 242
Innovative Designs (IVDN) 1,983 16% -3.4 -39% 1,630 747 256 42 -629 -605 2,030
Remsleep Holdings (RMSL) 1,981 -0.7 -1,055% 273 1,345 0 0 -2,881 -2,854 2,111
Intellinetics (INLX) 1,852 96% -4.0 -251% 868 6,330 1,829 1,755 -2,176 -1,258 4,975
Omnitek Engineering (OMTK) 1,838 47% -3.8 -39% 1,364 1,469 896 424 -530 -506 1,900

Balance Sheet ($'000)2017-12-312018-12-31
Cash389248
Accounts Receivable1,6731,387
Inventory3,5622,689
PP&E1,045888
Assets12,6278,462
Accounts Payable3,1233,133
Long-Term Debt2,8012,096
Liabilities10,99710,364
Stockholders' Equity1,630-1,902
Income Statement ($'000)2017-12-312018-12-31
Revenue40,21336,051
Cost of Revenue29,39026,926
Gross Profit10,8239,125
R&D
SG&A10,3609,252
Tax1,0292,028
Net Income-2,108-3,528
Cash Flow ($'000)2017-12-312018-12-31
Cash Operating630479
Cash Investing859-113
Cash Financing-1,461-507